Detalhe da pesquisa
1.
ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity.
Nature
; 579(7797): 130-135, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32076273
2.
Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses.
Drug Metab Dispos
; 50(7): 898-908, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35545256
3.
Substituted diaryl ether compounds as retinoic acid-related orphan Receptor-γt (RORγt) agonists.
Bioorg Med Chem Lett
; 35: 127778, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33422603
4.
Substituted benzyloxytricyclic compounds as retinoic acid-related orphan receptor gamma t (RORγt) agonists.
Bioorg Med Chem Lett
; 30(12): 127204, 2020 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32334911
5.
Saracatinib as a metastasis inhibitor in metastatic castration-resistant prostate cancer: A University of Chicago Phase 2 Consortium and DOD/PCF Prostate Cancer Clinical Trials Consortium Study.
Prostate
; 76(3): 286-93, 2016 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26493492
6.
microRNAs and Prostate Cancer.
Adv Exp Med Biol
; 889: 105-18, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26658999
7.
Application of Pharmacokinetic/Pharmacodynamic Modeling to Bridge Mouse Antitumor Efficacy and Monkey Toxicology Data for Determining the Therapeutic Index of an Interleukin-10 Fc Fusion Protein.
Front Pharmacol
; 13: 829063, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35795558
8.
Inhibition of ADAM9 expression induces epithelial phenotypic alterations and sensitizes human prostate cancer cells to radiation and chemotherapy.
Prostate
; 71(3): 232-40, 2011 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20672324
9.
MicroRNA 125b inhibition of B cell differentiation in germinal centers.
Int Immunol
; 22(7): 583-92, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20497960
10.
Early growth response genes regulate B cell development, proliferation, and immune response.
J Immunol
; 181(7): 4590-602, 2008 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18802061
11.
Regulatory signaling network in the tumor microenvironment of prostate cancer bone and visceral organ metastases and the development of novel therapeutics.
Asian J Urol
; 6(1): 65-81, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30775250
12.
In situ Hybridization (ISH) and Quantum Dots (QD) of miRNAs.
Bio Protoc
; 7(4): e2138, 2017 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34458458
13.
miRNA Characterization from the Extracellular Vesicles.
Bio Protoc
; 7(4): e2139, 2017 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34458459
14.
SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer.
Oncotarget
; 6(42): 44072-83, 2015 Dec 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26624980
15.
miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer.
Clin Cancer Res
; 20(24): 6559-69, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25324143
16.
miR-409-3p/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancer.
Clin Cancer Res
; 20(17): 4636-46, 2014 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24963047
17.
Inhibition of ß2-microglobulin/hemochromatosis enhances radiation sensitivity by induction of iron overload in prostate cancer cells.
PLoS One
; 8(7): e68366, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23874600
18.
Future perspectives of prostate cancer therapy.
Transl Androl Urol
; 1(1): 19-32, 2012 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-22773967
19.
ß2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells.
Cancer Res
; 71(7): 2600-10, 2011 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21427356
20.
Targeting the tumor-stromal-immune cell axis.
Oncoscience
; 2(9): 743-4, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26501076